MARIE GLORIE: Open Payments
NPI 1972112357 · DALLAS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 28 payments from 13 companies in 2025. Trend: 2023 $191 · 2024 $370 · 2025 $543
Food & beverage: $498Education: $45
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 6 | $115 |
| Novo Nordisk Inc | 5 | $86 |
| PFIZER INC. | 4 | $69 |
| ABBVIE INC. | 3 | $60 |
| Astellas Pharma US Inc | 2 | $47 |
| Abbott Laboratories | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24 |
| Dynavax Technologies Corporation | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| IBSA Pharma Inc. | 1 | $21 |
Products named: MOUNJARO, Veozah, UBRELVY, Ozempic, FREESTYLE LIBRE 3, JARDIANCE, Heplisav-B, UZEDY.
Industry payments across GA — which companies pay providers there.
